News for the Multiple Sclerosis Community

Oral drug teriflunomide study recruiting

This study will assess the safety and effectiveness of an investigational study medication versus placebo (an inactive substance which contains no active medication) in people ages 18-55 years old with RRMS.

The investigational medication used in this study is called teriflunomide. You can find out more about participating here.